DeFi Daily News
Monday, June 30, 2025
Advertisement
  • Cryptocurrency
    • Bitcoin
    • Ethereum
    • Altcoins
    • DeFi-IRA
  • DeFi
    • NFT
    • Metaverse
    • Web 3
  • Finance
    • Business Finance
    • Personal Finance
  • Markets
    • Crypto Market
    • Stock Market
    • Analysis
  • Other News
    • World & US
    • Politics
    • Entertainment
    • Tech
    • Sports
    • Health
  • Videos
No Result
View All Result
DeFi Daily News
  • Cryptocurrency
    • Bitcoin
    • Ethereum
    • Altcoins
    • DeFi-IRA
  • DeFi
    • NFT
    • Metaverse
    • Web 3
  • Finance
    • Business Finance
    • Personal Finance
  • Markets
    • Crypto Market
    • Stock Market
    • Analysis
  • Other News
    • World & US
    • Politics
    • Entertainment
    • Tech
    • Sports
    • Health
  • Videos
No Result
View All Result
DeFi Daily News
No Result
View All Result
Home Other News Health

Reelin protein consistently appears in the brains of individuals who show resistance to aging and Alzheimer’s.

Jon Hamilton by Jon Hamilton
July 29, 2024
in Health
0 0
0
Reelin protein consistently appears in the brains of individuals who show resistance to aging and Alzheimer’s.
0
SHARES
0
VIEWS
Share on FacebookShare on TwitterShare on Telegram
Listen to this article

A key protein called Reelin may help stave off Alzheimer’s disease, according to a growing body of research.

GSO Images/The Image Bank/Getty Images

hide caption

toggle caption

GSO Images/The Image Bank/Getty Images

A key protein that helps assemble the brain early in life also appears to protect the organ from Alzheimer’s and other diseases of aging.

A trio of studies published in the past year all suggest that the protein Reelin helps maintain thinking and memory in ailing brains, though precisely how it does this remains uncertain. The studies also show that when Reelin levels fall, neurons become more vulnerable.

There’s growing evidence that Reelin acts as a “protective factor” in the brain, says Li-Huei Tsai, a professor at MIT and director of the Picower Institute for Learning and Memory.

“I think we’re on to something important for Alzheimer’s,” Tsai says.

Various pieces of colorful trash, such as plastic bottle caps and plastics forks, are arranged in the shape of a human brain, on a light blue background.

The research has inspired efforts to develop a drug that boosts Reelin or helps it function better, as a way to stave off cognitive decline.

“You don’t have to be a genius to be like, ‘More Reelin, that’s the solution,’” says Dr. Joseph Arboleda-Velasquez of Harvard Medical School and Massachusetts Eye and Ear. “And now we have the tools to do that.”

From Colombia, a very special brain

Reelin became something of a scientific celebrity in 2023, thanks to a study of a Colombian man who should have developed Alzheimer’s in middle age but didn’t.

The man, who worked as a mechanic, was part of a large family that carries a very rare gene variant known as Paisa, a reference to the area around Medellin where it was discovered. Family members who inherit this variant are all but certain to develop Alzheimer’s in middle age.

This PET image shows the brain of a Colombian man whose memory and thinking remained intact in his late 60s, even though he carried a rare gene variant that nearly always causes Alzheimer's in a person's 40s.

This PET image shows the brain of a Colombian man whose memory and thinking remained intact in his late 60s, even though he carried a rare gene variant that nearly always causes Alzheimer’s in a person’s 40s.

Yakeel T. Quiroz-Gaviria and Justin Sanchez/Massachusetts General Hospital

hide caption

toggle caption

Yakeel T. Quiroz-Gaviria and Justin Sanchez/Massachusetts General Hospital

“They start with cognitive decline in their 40s, and they develop full-blown dementia [in their] late 40s or early 50s,” Arboleda-Velasquez says.

But this man, despite having the variant, remained cognitively intact into his late 60s and wasn’t diagnosed with dementia until he was in his 70s.

After he died at 74, an autopsy revealed that the man’s brain was riddled with sticky amyloid plaques, a hallmark of Alzheimer’s.

Scientists also found another sign of Alzheimer’s — tangled fibers called tau, which can impair neurons. But oddly, these tangles were mostly absent in a brain region called the entorhinal cortex, which is involved in memory.

Want to understand your adolescent? Get to know their brain

That’s important because this region is usually one of the first to be affected by Alzheimer’s, Arboleda-Velasquez says.

The researchers studied the man’s genome. And they found something that might explain why his brain had been protected.

He carried a rare variant of the gene that makes the protein Reelin. A study in mice found that the variant enhances the protein’s ability to reduce tau tangles.

Although the research focused on a single person, it reverberated through the world of brain science and even got the attention of the (then) acting director of the National Institutes of Health, Lawrence Tabak.

“Sometimes careful study of even just one truly remarkable person can lead the way to fascinating discoveries with far-reaching implications,” Tabak wrote in his blog post about the discovery.

Reelin gets real

After the study of the Colombia man was published, lots of researchers “started to get excited about Reelin,” Tsai says.

Tsai’s team, though, had already been studying the protein’s role in Alzheimer’s.

In September of 2023, the team published an analysis of the brains of 427 people. It found that those who maintained higher cognitive function as they aged tended to have more of a kind of neuron that produces Reelin.

In July of 2024, the group published a study in the journal Nature that provided more support for the Reelin hypothesis.

The study included a highly detailed analysis of post-mortem brains from 48 people. Twenty-six brains came from people who had shown symptoms of Alzheimer’s. The rest came from people who appeared to have normal thinking and memory when they died.

Interestingly, a few of these apparently unaffected people had brains that were full of amyloid plaques.

“We wanted to know, ‘What’s so special about those individuals?’” Tsai says.

So the team did a genetic analysis of the neurons in six different brain regions. They found several differences, including a surprising one in the entorhinal cortex, the same region that appeared to be protected against tau tangles in the man from Colombia.

“The neurons that are most vulnerable to Alzheimer’s neurodegeneration in the entorhinal cortex, they share one feature,” Tsai says: “They highly express Reelin.”

With early Alzheimer's in the family, these sisters decided to test for the gene

In other words, Alzheimer’s appears to be selectively damaging the neurons that make Reelin, the protein needed to protect the brain from disease. As a result, Reelin levels decline and the brain becomes more vulnerable.

The finding dovetails with what scientists learned from the Colombian man whose brain defied Alzheimer’s. He had carried a variant of the RELN gene that seemed to make the protein more potent. So that might have offset any Reelin deficiency caused by Alzheimer’s.

At the very least, the study “confirms the importance of Reelin,” Arboleda-Velasques says, “which, I have to sa…

The Reelin story might never have emerged without the cooperation of about 1,500 members of an extended Colombian family that carries the Paisa gene variant.

The first members of that family were identified in the 1980s byDr. Francisco Lopera Restrepo, head of the University of Antioquia’s Clinical Neurology Department. Since then, members have taken part in a range of studies, including trials of experimental Alzheimer’s drugs.

Along the way, scientists have identified a handful of family members who inherited the Paisa gene variant but have remained cognitively healthy well beyond the age when dementia usually sets in.

Some appear to be protected by an extremely rare version of the APOE gene called the Christchurch variant. Now scientists know that others seem to be protected by the gene responsible for Reelin.

Both of those discoveries were possible because some members of the Colombian family have been examined repeatedly in their own country, and even flown to Boston for brain scans and other advanced tests.

“These people agreed to participate in research, get their blood drawn, and donate their brain after death,” Arboleda-Velasquez says. “And they changed the world.”

## Conclusion

In conclusion, the research surrounding the protein Reelin and its potential role in protecting the brain from Alzheimer’s disease and other age-related cognitive decline is promising. The studies discussed in this article provide compelling evidence that Reelin plays a crucial role in maintaining brain health and function, and that boosting Reelin levels may be a viable strategy for preventing cognitive decline in aging individuals.

As researchers continue to unravel the mysteries of the brain and its relationship to neurodegenerative diseases, the discovery of Reelin’s protective effects opens up new avenues for potential treatments and interventions. By understanding how this key protein operates in the brain and how it can help combat the effects of Alzheimer’s, scientists are hopeful that they can develop targeted therapies that may one day prevent or slow down the progression of these debilitating conditions.

## FAQs

1. **What is Reelin and why is it important?**
Reelin is a key protein that helps assemble the brain early in life and also appears to protect it from diseases like Alzheimer’s as we age. Its role in maintaining cognitive function and memory is crucial for overall brain health.

2. **How does Reelin protect the brain from Alzheimer’s?**
Research suggests that Reelin acts as a protective factor in the brain, helping to maintain thinking and memory in ailing brains. When Reelin levels fall, neurons become more vulnerable, making the brain susceptible to diseases like Alzheimer’s.

3. **Are there efforts to develop drugs that target Reelin for Alzheimer’s prevention?**
Yes, efforts are underway to develop drugs that either boost Reelin levels or enhance its function in the brain as a way to stave off cognitive decline associated with aging and neurodegenerative diseases like Alzheimer’s.

For more trending news articles like this, visit [DeFi Daily News](http://defi-daily.com).



Source link

Tags: AgingAlzheimersAppearsbrainsconsistentlyIndividualsproteinReelinResistanceshow
ShareTweetShare
Previous Post

Report Reveals Apple Intelligence Feature to Miss Initial iOS 18 Launch Rollout

Next Post

The latest Nest Thermostat from Google features an enhanced user interface and a sleek, “borderless” display

Next Post
The latest Nest Thermostat from Google features an enhanced user interface and a sleek, “borderless” display

The latest Nest Thermostat from Google features an enhanced user interface and a sleek, "borderless" display

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
  • Trending
  • Comments
  • Latest
rewrite this title SEI Leads Crypto Market With 43% Weekly Surge – alt=

rewrite this title SEI Leads Crypto Market With 43% Weekly Surge – $0.5 Reclaim In The Horizon?

June 28, 2025
rewrite this title High Season, High Stakes: Navigating Summer Risks in Property Management

rewrite this title High Season, High Stakes: Navigating Summer Risks in Property Management

June 27, 2025
They’re Going ALL IN on Crypto: This is What Wall St is Buying!

They’re Going ALL IN on Crypto: This is What Wall St is Buying!

June 25, 2025
rewrite this title ‘FIFA Rivals’ Review: Should You Play This NFT Soccer Game? – Decrypt

rewrite this title ‘FIFA Rivals’ Review: Should You Play This NFT Soccer Game? – Decrypt

June 28, 2025
rewrite this title with good SEO Bitcoin Could Explode On Bessent’s 0 Billion Deregulation Shock

rewrite this title with good SEO Bitcoin Could Explode On Bessent’s $250 Billion Deregulation Shock

May 28, 2025
Mastering Crypto Mining: A Step-By-Step Guide

Mastering Crypto Mining: A Step-By-Step Guide

September 12, 2024
rewrite this title South Korea Halts CBDC Phase 2 Testing Amid Stablecoin Surge and Uncertainty

rewrite this title South Korea Halts CBDC Phase 2 Testing Amid Stablecoin Surge and Uncertainty

June 30, 2025
rewrite this title Why 95% of phishing attacks go unreported in healthcare

rewrite this title Why 95% of phishing attacks go unreported in healthcare

June 30, 2025
rewrite this title Dwayne Johnson inducts “The Smashing Machine” Mark Kerr into UFC Hall of Fame

rewrite this title Dwayne Johnson inducts “The Smashing Machine” Mark Kerr into UFC Hall of Fame

June 30, 2025
rewrite this title Universal Stella Nova Review: Park Perks, Great Value – NerdWallet

rewrite this title Universal Stella Nova Review: Park Perks, Great Value – NerdWallet

June 30, 2025
rewrite this title Metaverse And Web3: From Early Hype To Practical Applications And Sector Integration

rewrite this title Metaverse And Web3: From Early Hype To Practical Applications And Sector Integration

June 30, 2025
rewrite this title Crypto Regulation Gets Tough in Turkey With New Limits and Penalties 

rewrite this title Crypto Regulation Gets Tough in Turkey With New Limits and Penalties 

June 30, 2025
DeFi Daily

Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.

  • About Us
  • Blogs
  • DeFi-IRA | Learn More.
  • Advertise with Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Cryptocurrency
    • Bitcoin
    • Ethereum
    • Altcoins
    • DeFi-IRA
  • DeFi
    • NFT
    • Metaverse
    • Web 3
  • Finance
    • Business Finance
    • Personal Finance
  • Markets
    • Crypto Market
    • Stock Market
    • Analysis
  • Other News
    • World & US
    • Politics
    • Entertainment
    • Tech
    • Sports
    • Health
  • Videos

Copyright © 2024 Defi Daily.
Defi Daily is not responsible for the content of external sites.